Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...

Recently, the US FDA approved initial combination therapy with sitagliptin and metformin (Janumet™) in order to help more patients with Type 2 diabetes mellitus get closer to accepted glycemic ...

These medications were sitagliptin, liraglutide, glimepiride, or insulin glargine U-100. Sitagliptin, liraglutide, and glimepiride increase the body’s insulin production in different ways, while ...

Change from baseline A1c (adjusted mean*)-0.9-0.2 Change from baseline FPG (adjusted mean*)-17 1 Intent-to-treat population using last observation on study prior to metformin rescue therapy.

The latest verdict – in a federal appeals court – has upheld the validity of a key patent on sitagliptin, the active ingredient in Januvia, as well as metformin ... with more than 20 other ...